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Abstract
Amphibians have provided important model systems to study transepithelial transport, acid–base balance and cell volume regulation.
Several families of chloride channels and transporters are involved in these functions. The purpose of this review is to report briefly on some
of the characteristics of the chloride channels so far reported in amphibian epithelia, and to focus on recently cloned members of the ClC
family and their possible physiological roles. The electrophysiological characterisation, distribution, localisation and possible functions are
reviewed and compared to their mammalian orthologs.
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1. Introduction
Anion channels are present in all biological membranes,
including plasma membranes and membranes of intracellular
organelles (reviewed in Ref. [1]). Like all gated channels,
they allow the passive diffusion of anions along their electro-
chemical gradients. Because chloride is the most abundant
inorganic anion in the intra- and extracellular media, anion
channels are commonly referred to as chloride channels. The
gating properties of these channels are closely related to their
function. Chloride channels are involved in various functions
that may be housekeeping, or specialised and restricted to a
particular tissue or cell type. Plasma membrane chloride
channels play an important role in transepithelial transport
involved in maintaining ionic homeostasis and acid–base
balance. Plasma membrane chloride channels are also in-
volved in cell volume regulation. This is particularly impor-
tant for epithelial cells that are subjected to large and variable
bulk flows. Another role of chloride channels at the plasma
membrane is the control of membrane excitability, in partic-
ular in skeletal muscle, smooth muscle and neurons. Intra-
cellular chloride channels are involved in setting the pH of
different intracellular compartments, for instance along the
endocytic pathway, in lysosomes and synaptic vesicles.
However, the study of intracellular channels is technically
more challenging and thus, little is known about their func-
tional characteristics.
Amphibians are aquatic or semiaquatic animals that can
adapt to live in water, which may vary from very low salt-
containing water to brackish or even salty water [2]. Such
adaptations are made possible through the specialisation of
epithelia, including the skin, intestine, kidney, and urinary
bladder allowing the control of the hydro-mineral and the
acid–base balance of the internal medium of these animals.
Amphibians have therefore provided important model sys-
tems to study transepithelial transport, acid–base balance,
and cell volume regulation.
The purpose of this review is to describe the involvement
of chloride channels in the above mentioned physiological
functions that have been extensively studied in amphibian
models, particularly adult frogs (Rana esculenta) and toads
(Bufo viridis and Xenopus laevis). We focus particularly on
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the distribution, cellular localisation, and functional charac-
terisation of two amphibian chloride channels: xClC-5 and
xClC-3.
2. Transepithelial chloride transport, ionic homeostasis,
and acid–base balance
The frog skin has been extensively used as a model to
study Na+ transport in epithelia. Cells of the outermost cell
layer possess tight junctions [3] and communicate with the
deeper cell layers by gap junctions [4]. This cell layer is
composed of two main ion transporting cell types, principal
cells and mitochondria-rich cells (MR cells) [5]. Due to its
cellular and functional organisation, this highly polarised
epithelium was proposed to behave as a syncitium [6,7]. The
‘‘Ussing model’’ has drawn the fundamental lines of our
understanding concerning active salt absorption in tight
epithelia [6]. The short-circuited skin bathed on both sides
with a Ringer solution and mounted in a Ussing chamber
has been a key tool in this context. In the process of active
salt absorption, Na+ is considered as a major player because
it is the sole actively transported ion. Chloride ions have
played the secondary role of an ‘‘accompanying anion’’
maintaining the electroneutrality of ion transfer. However, a
large chloride transport (and conductance) occurs through
skins bathed in high NaCl-containing media under open
circuited conditions or imposed voltages similar to physio-
logical transepithelial potentials [8–10]. This passive chlor-
ide conductance, activated by voltage and by high chloride
concentrations is regulated by second messengers and
hormones; this phenomenon has been particularly studied
in toads (reviews in Refs. [11,12]). Patch-clamp experiments
allowed the identification of chloride channels that mediate
CFTR-like currents in MR cells, suggesting that these cells
are responsible for the transepithelial chloride conductance
(Refs. [13,14]; Larsen, this issue). The existence of a
chloride conductance in MR cells is in agreement with the
early finding of a positive correlation between the number
of MR cells and the transepithelial Cl conductance [15].
Nevertheless, the existence of a paracellular pathway for
Cl has also been implicated [16], and the relative contri-
bution of each pathway is still not solved (Refs. [11,12];
Nagel and Larsen, this issue). The physiological signifi-
cance of this transepithelial chloride conductance remains to
be clarified in toads as well as in frogs where it has also
been reported [17].
Most amphibians that live in freshwater have to face a low
NaCl concentration ( < 1 mM) in the ambient medium.
Therefore, the reabsorption of Na+ and of Cl is active and
requires complex transport mechanisms. The reabsorption of
Na+ and Cl is achieved by separate and independent anion-
and cation-transporting mechanisms initially described in
vivo [18–22], and later in vitro [10,23,24]. The rate of net
absorption of sodium and chloride can be different, depend-
ing on the hydro-mineral and acid–base status of the animals
[25], thus demonstrating a fine regulatory process. In agree-
ment with the Ussing model, sodium ions diffuse through
amiloride-sensitive sodium channels [26,27] located on the
apical membranes of principal cells and of MR cells [25,28].
Na+ ions are then pumped into the ‘‘milieu inte´rieur’’ by the
Na+ pump located on the basal membranes. The electro-
chemical driving force for the apical Na+ entry depends
mainly on the activity of an electrogenic V-ATPase, which
provides the negative cell potential that compensates for the
unfavourable chemical gradient [29–31]. Therefore, an
indirect electrical coupling links the proton pump to sodium
entry and accounts for the correlation between sodium
absorption and proton secretion. In this scheme of Na+
reabsorption from very dilute solutions, two different pumps
functioning in series are required: the H+ pump and the Na+
pump. This frog skin model in which MR cells play a key
role has been extended to freshwater fishes [32,33] and salt-
depleted crustaceans [34].
The active chloride absorption that parallels reabsorption
of sodium from low salt containing media, is electrically
coupled to the proton pump and participates in the regu-
lation of ion homeostasis and the acid–base balance of the
organism. In MR cells, the electric gradient provided by the
V-ATPase energises the electroneutral Cl/HCO3
 ex-
changer at the apical membrane [35]. Thus, absorbed Cl
ions are exchanged for secreted bicarbonate [24,36]. This
secondary active mechanism presents an apparent affinity
for chloride of 0.2 mM in R. esculenta frog skin [9]. In
isolated skins of amphibians bathed with isotonic Ringer
solutions, this exchange mechanism still exists, but allows
only a small portion of chloride transport compared to
conductive chloride absorption [9,11].
A model illustrating the key roles of MR cells and of V-
ATPase in energising chloride and sodium transport in frog
skin is given in Fig. 1.
3. Anion channels and cell volume regulation
Many cell functions such as epithelial transport, cell
proliferation, and apoptosis require cell volume regulatory
mechanisms (for a review, see Ref. [37]). Anion channels
have been implicated in cell volume regulation following
cell swelling (also called regulatory volume decrease or
RVD). Cell swelling is caused by acute changes in medium
osmolarity (hyposmotic shocks) or by metabolic changes.
The recovery (shrinkage) back to the initial cell volume is
achieved by the opening of potassium and anion channels
that in turn drive water exit. Several different anion chan-
nels, distinguishable by their electrophysiological character-
istics, have been reported in amphibian kidney cells upon an
hyposmotic challenge [38], but one channel type is reported
in most models studied, the so called VSOAC for volume
sensitive organic osmolyte and anion channel (also called
volume regulated anion channel, VRAC). This channel
presents an outwardly rectified anion conductance, a char-
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acteristic pharmacology and anion selectivity. In addition, it
is permeable to small organic osmolytes including taurine,
myo-inositol or sorbitol (for reviews, see Refs. [39,40]).
Amphibian epithelial models used to study cell volume
regulation include frog skin (in particular MR cells)
[41,42], renal cells [43,44], and urinary bladder cells [45].
In addition to these epithelial cells, Xenopus oocytes have
been particularly useful to study the cell volume activated
chloride conductance present in manually defolliculated
oocytes [46]. A comparison of the electrophysiological
characteristics of the volume-sensitive anion conductance
in Xenopus oocytes and A6 renal cells is given in Table 1. In
Fig. 1. V-ATPase in MR cells energises ion transport in frog skin. Upper part: V-ATPase immunoreactivity of MR cells in R. esculenta skin epithelium viewed
by epifluorescence illumination (a), the same view by differential interference contrast is shown in (b) (from Ref. [11]). The frog skin epithelium presents
different cell layers (stratum corneum, stratum granulosum, stratum spinosum, and basal lamina). Two MR cells are clearly distinguishable in the outermost cell
layer (c). Lower part: (A) Model of ion reabsorption from low salt containing media. The electrogenic proton pump (V-ATPase) in MR cells energizes the Na+
entry (through amiloride sensitive sodium channels present in granular (GR) and MR cells) and the Cl/HCO3 exchanger present in the same MR cells [11,35].
(B) Model of ion reabsorption in isotonic saline. A large chloride conductance is present in high salt containing solutions; the relative contribution of the
cellular pathway through MR cells [11] and a paracellular pathway [12] is not solved. For clarity, the Cl/HCO3 exchanger (A) is not represented here; its
contribution to chloride absorption is smaller than that of the chloride conductance, but it is nevertheless significant [9,11].
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these two amphibian models, the volume-sensitive anion
conductances present similar levels of outward rectification
and similar sensitivities to the pharmacology (4,4V-diisothio-
cyanatostilbene-2,2V-disulfonic acid (DIDS), oxonol, and 5-
nitro-2-(3-phenylpropylamino)-benzoic acid (NPPB) block-
ade). Osmo-sensitive taurine effluxes are also blocked by
these inhibitors and the IC50 (5 AM) of oxonol (one of the
most effective blockers) in A6 cells compares to that found
for RVD (mediated by Cl and K+ exit), suggesting the
presence of a common pathway for chloride and taurine
(unpublished data). However, the discrepancies in the ef-
fects observed with ketoconazole and extracellular nu-
cleotides could be explained by the existence of multiple
osmo-sensitive chloride channels [38]. Even though our
knowledge of the properties of the volume-sensitive anion
conductance and the signalling pathways involved in its
regulation have progressed this past decade (for reviews, see
Refs. [40,47]), the molecular identity of the channel protein
is still unknown.
4. Molecular characterisation of amphibian chloride
channels of the ClC family
Chloride channels are encoded by at least three different
gene families. The largest is the gene family that encodes the
pentameric ligand-gated chloride channels [1,48,49]. The
ClC gene family encodes voltage-dependent chloride chan-
nels that are thought to function as dimers and may require
additional h subunits to function [1]. The cystic fibrosis
transmembrane conductance regulator (CFTR) belongs to
the ABC transporter gene family, but is so far the only one in
this family that functions as a chloride channel and also as a
channel regulator [1,50,51]. Another emerging chloride
channel gene family is that of the CLCA family, which is
thought to encode calcium-activated chloride channels (also
referred to as CaCC) [1,52,53]. However, more chloride
channel genes remain to be discovered, such as swelling
activated chloride channels (and possibly CaCC). Also, not
all identified chloride channels have been attributed a func-
tion. The difficulties in correlating a chloride channel with a
particular function result from the lack of specificity of the
pharmacology for a broad diversity of chloride channels. In
addition, the study of chloride channel function is hampered
by the presence of endogenous chloride channels in virtually
every cell system used for functional expression.
To date, only four chloride channels have been cloned
from amphibians: the Xenopus homologue of CFTR [54],
the Xenopus homologue of ClC-K [55], and the Xenopus
homologues of ClC-5 and ClC-3, which were identified in
our laboratory (Ref. [56]; our unpublished data), by the
following strategy.
A rapid amplification of cDNA ends-polymerase chain
reaction (RACE-PCR) cloning strategy was carried out to
isolate amphibian homologues of the ClC gene family from
A6 renal cells. Amplifications were based on degenerate
oligonucleotide primers designed from consensus sequences
of the Torpedo ClC-0 and the mammalian ClC-1, -2 and -K
sequences published at the time of the beginning of our
experiments. We identified two novel sequences of 2586 bp
(a) and of 3016 bp (b), both showing significant similarity to
ClC genes. A translation product of 791 amino acids with a
molecular mass of 88 kDa is predicted from the open
reading frame (ORF, nucleotides 91–2464) from the first
sequence (a) when the initiation methionine is assigned to
the first ATG codon in-frame. A 808-amino acid translation
product with a molecular mass of 90 kDa can be deduced
from the second sequence (b). An amino acid identity of
69% is found between the two sequences. A database search
using the BLASTN program revealed extremely high sim-
Table 1
Comparison of the swelling-activated chloride current and taurine effluxes in two Xenopus model cells: oocytes and renal cells






Osmotic stimulation Yesa Yesa,b,c Yesa Yesd,e
Outward rectification Yesa,b,c Yesd,e
Localisation Basolateral membranesa Basolateral membranesd
Pharmacology
DIDS Blocksa Blocksa Blocksa Blocksd,e
Oxonol Blocksa Blocksa Blocksa Blocksd
NPPB blocks Blocksa Blocksb Blocksa Blocksd,e
Ketoconazole Blocksa No effecta Slightly blocksd
Extracellular nucleotide Stimulatesa ? Blocksa Blocksd,e
Lanthanum ? ? Blocksd,e
a Our unpublished data.
b From Ref. [105].
c From Ref. [38].
d From Ref. [66].
e From Ref. [46].
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ilarities of the isolated sequences to other sequences of ClC
proteins identified meanwhile. Sequences (a) and (b) were
identified as the amphibian orthologs of mammalian ClC-3
and ClC-5, respectively. Therefore, the new sequences were
termed xClC-3 and xClC-5 (where ‘‘x’’ stands for Xenopus).
Amphibian ClC-3 protein displays 89% identity to human
ClC-3 [57], 90% to rat and mouse ClC-3 [57,58], 90% to
guinea pig ClC-3 [59] and 86% to teleost fish ClC-3 [60].
Xenopus ClC-5 protein has 78% identity to its human and
rat orthologs [61,62]. If the 5th methionine of the open
reading frame is considered as the initiation ATG, the
identity to the mammalian orthologs increases to 85%,
respectively. The two polypeptides both display the typical
primary structure of members of the ClC family, i.e. con-
taining the characteristic 13 hydrophobic domains. As most
ClC channels, both amphibian ClC amino acid sequences
show a highly conserved potential N-glycosylation site
located between hydrophobic regions D8 and D9. Several
motifs for potential phosphorylation by protein kinase C
(PKC) and phosphorylation by cAMP- and guanosine 3V,5V-
cyclic monophosphate-dependent protein kinase are present
in both sequences.
5. Xenopus oocytes: expression system of choice for
electrophysiological characterisation of channel proteins
The Xenopus oocyte is the expression system of choice
for electrophysiological studies of channel proteins and
transporters. A large number of oocytes can be easily
obtained from a single female and the large size (about
1.2–1.3 mm in diameter) of the oocytes allows the micro-
injection of mRNA of the protein(s) of interest followed by
voltage-clamp analysis using double microelectrodes. The
oocytes can also be used for biochemical studies to assess
protein expression, localisation, and posttranslational mod-
ifications. However, the proteome of the amphibian oocyte
does not necessarily include accessory and regulatory pro-
teins required for proper functioning, trafficking, or regu-
lation of the exogenously expressed proteins. Moreover,
Xenopus oocytes express endogenous channel proteins,
which can be activated under various circumstances and
contribute to measured currents or even interfere with the
activity of exogenous proteins. Some endogenous channel
activities are well known, such as the transient calcium-
activated chloride current initially described by Miledi and
Parker [63], or the hyposmotically activated chloride current
ICl swell, which appears only in manually defolliculated
oocytes [46]. Another constitutive chloride current that is
activated by an unknown mechanism has been described in
several studies [64–66]. Among the endogenous chloride
channel proteins, xClC-3 and xClC-5 are the only ones that
have been characterised at the molecular level (Ref. [56];
our unpublished results). Although high levels of ClC-3 and
ClC-5 mRNA have been found, only small amounts of these
proteins are synthesised. To date, these channels have not
been described to interact with exogenous proteins, in
particular ClCs. Even though ClC channels have been
described to form multimers with novel properties [67],
the electrophysiological properties of ClCs appeared the
same when they were studied in mammalian cell systems
[68,69]. The absence of interaction of endogenous ClCs
with exogenous ClCs is probably due to their low expres-
sion level and their likely intracellular localisation in the
oocyte.
6. Functional characterisation of amphibian chloride
channels of the ClC family
6.1. xClC-3
6.1.1. Electrophysiological characterisation
Expression of xClC-3 as well as of ClC-3 orthologs in
Xenopus oocytes or mammalian cell systems did not yield
any novel currents in the hands of several groups (Ref.
[57,62,68,70]; our unpublished results; Fig. 2). The absence
of ClC-3 currents could be due to a lack of regulatory
elements or a h subunit. Barttin has recently been identified
as a h subunit necessary for ClC-K channel function [71].
However, it is more likely to be due to the intracellular
localisation of the channel. Nevertheless, several other
groups reported functional expression of ClC-3. The first
reports of ClC-3 expression by Kawasaki et al. [58,72]
describe currents with divergent characteristics found in
different expression systems and an I>Cl selectivity that
is not consistent with the selectivity observed with other
ClC channels. Duan et al. [59] reported that expression of
ClC-3 yielded swelling-activated currents with a I>Cl
selectivity and demonstrated specific effects in the current
characteristics with several point mutations [73,74]. Finally,
ClC-3 currents with electrophysiological characteristics
resembling the closely related ClC-4 and ClC-5 channels
(rectification, insensitivity to DIDS or hyposmotic stress,
and Cl>I) have been recently reported in CHO-K1 cells
[75]. The divergence of these reports and of the current
characteristics associated with ClC-3 in different expression
systems is probably related to the difficulty to distinguish
between endogenous currents and expressed currents.
6.1.2. Distribution, localisation, and functional model
RNase protection assays (RPA) have shown that xClC-3
is a rather broadly expressed gene in X. laevis. A high
expression level was found in the central nervous system,
and significant levels of expression were also observed in
kidney, intestine, skeletal muscle and lung (S. Lindenthal,
unpublished data). In rodent, a broad tissue distribution of
ClC-3 was reported at the mRNA level [58] and at the
protein level [76,77], with highest expression levels in brain.
Polyclonal antibodies against a C-terminal peptide of
xClC-3 were raised. On Western blots with membranes of
xClC-3 expressing Xenopus oocytes, a broad band at 105
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kDa was revealed (Fig. 3A). After enzymatic deglycosyla-
tion, xClC-3 protein migrated as a lower molecular mass
band of about 85 kDa close to its calculated molecular mass
of 88 kDa. Endogenous xClC-3 expression in A6 cells and
in Xenopus kidney was also analysed on immunoblots.
Similar to xClC-3 expressed in Xenopus oocytes, endoge-
nous ClC-3 in A6 cells is highly glycosylated and migrates
at a molecular mass of 105 kDa (Fig. 3B). In mouse, mClC-
3 is also highly glycosylated and was found to undergo
differential tissue-specific N-glycosylation [77].
Localisation of endogenous xClC-3 in A6 cells by
immunocytochemistry shows extensive intracellular stain-
ing (our unpublished observations). This localisation is
consistent with recent studies showing the presence of
mammalian ClC-3 in endosomes and synaptic vesicles
[76]. In ClC-3 knock-out mice, acidification of synaptic
vesicles was found to be impaired, and led the authors to
propose that the ClC-3 conductance may function as an
electrical shunt for the proton pump (V-ATPase) to facilitate
intravesicular acidification [76]. Labeling of cell surface
proteins showed that ClC-3 can be found at the plasma
membrane under some conditions of overexpression [70].
Whether endogenous ClC-3 protein can also reach the
plasma membrane remains to be examined. Recently, a
splice variant of ClC-3, called ClC-3B, has been cloned
from human pancreas [78]. This ClC-3B variant is
expressed mainly in epithelial cells, and interacts with the
PDZ-domain protein EBP50 (also called NHERF1), which
is also known to interact with CFTR [79]. Interestingly, co-
transfection of ClC-3B and EBP50 induced the activity of
the outwardly rectifying chloride channel (ORCC) at the
leading edges of the cells. This led the authors to propose
that ClC-3B may function as the CFTR-regulated ORCC or
as a regulator of ORCC (through the regulation of ORCC
Fig. 2. Electrophysiological properties of IxClC-3 and IxClC-5. Representative traces of currents of (A) water-, (B) xClC-3 cRNA- and (C) xClC-5 cRNA-injected
oocytes. The oocytes were investigated by voltage-clamp 4 days after injection of 5 ng cRNA/oocyte or water. Oocytes were sequentially clamped from a
holding potential of  50 mV to voltages between  100 and + 80 mV for 800 ms in steps of 20 mV. (D) Mean current–voltage (I/V) relationships of water-
injected oocytes (y, n= 17), xClC-3 cRNA-injected oocytes (n, n= 17) and xClC-5 cRNA-injected oocytes (E, n= 15). Data from Ref. [66] and our
unpublished data. Methods are as described in Ref. [66].
S. Schmieder et al. / Biochimica et Biophysica Acta 1566 (2002) 55–6660
trafficking) [78]. However, it is not yet clear whether ClC-
3B channels reach the plasma membrane when transfected
into C127 cells.
The xClC-3 cDNA that we identified is similar to ClC-
3A [78], but the presence of a ClC-3 splice variant (xClC-
3B) in amphibian chloride secreting epithelia (as A6 cells)
remains a possibility that requires further examination.
Future studies to elucidate the function of ClC-3 splice
variants in h-intercalated cells in rat kidney [80], as well as
in fish and amphibian intestines (our unpublished observa-
tions), are also required.
6.2. xClC-5
6.2.1. Electrophysiological characterisation
To date, ClC-5 orthologs from human, rat, mouse, pig,
guinea-pig, and Xenopus have been functionally expressed in
either Xenopus oocytes or mammalian cell lines (HEK 293,
COS-7, and CHO-K1) (Table 2). The functional character-
istics of the amphibian xClC-5 have been studied in Xenopus
oocytes and COS-7 cells. In both systems, the currents
associated with xClC-5 expression, IClC-5 appeared voltage
dependent. The current–voltage relationship of IClC-5 shows
a strong outward rectification, with significant currents only
for membrane potentials higher than + 20 mV (Fig. 2). The
currents observed with ClC-5 orthologs are equally outward
rectified. The physiologic relevance of such a strong voltage-
dependence is not understood yet. ClC-5 has been localised
in early endosomes [81]. The membrane potential of this
intracellular compartment is not documented and it is there-
fore not known whether the membrane potential would allow
ClC-5 activity. Also, the association with some regulatory
factor or h subunit might shift the voltage-dependence of the
current towards more physiologic potentials.
Due to the strong outward rectification of the current, it is
not possible to define the relative anion permeability se-
quence. Therefore, only the conductivity sequence at posi-
tive membrane potentials could be determined. We deter-
Table 2
Comparison of electrophysiological characterisations of CIC-5 orthologs
Species Expression system Rectification Conductivity sequence pH sensitivitya Pharmacologyb Reference
Rat Xenopus oocytes strong outward NO3
>Cl>Br>IHglutamate – no effects [62]
Xenopus Xenopus oocytes strong outward NO3
>Br>Cl>IHgluconate yes no effects [66]
Human Xenopus oocytes strong outward – yes – [68]
Human HEK 293 strong outward – yes – [68]
Xenopus Xenopus oocytes strong outward NO3
>Cl = I>bicarbHglutamate yes no effects [69]
Human Xenopus oocytes strong outward NO3
>Cl>bicarb>IHglutamate yes no effects [69]
Pig Xenopus oocytes strong outward NO3
>Cl>Br>acetate>IHgluconate yes no effects [88]
Xenopus COS-7 strong outward Cl>I yes – [82]
Guinea pig HEK 293 strong outward NO3
>Cl>Br>I>FHgluconate – – [106]
Mouse CHO-K1 strong outward – – no effects [107]
a Inhibition by acidic extracellular medium.
b Commonly used chloride channel inhibitors (DIDS, NPPB, DPC).
Fig. 3. Western blot analysis of xClC-3 from cRNA-injected Xenopus oocytes and A6 cells, and enzymatic deglycosylations. Membrane preparations obtained
from xClC-3 cRNA-injected oocytes (A) and A6 cells (B) were incubated at 37 jC for 2 h without (‘‘control’’, lane a) and with endoglycosidase H
(‘‘ + EndoH’’, lane b) or endoglycosidase F/N-glycosidase F mixture (‘‘ + EndoF/N-GlycoF’’, lane c) prior to separation on SDS/PAGE and immunoblotting.
Endoglycosidase H digestion had no effect on xClC-3 from injected oocytes and A6 cells. For both samples, digestion with the endoglycosidase F/N-
glycosidase F enzyme mixture led to a shift of the recognised band from 105 to 85 kDa corresponding to the calculated molecular mass of unglycosylated
xClC-3 protein. Methods are as described in Ref. [77]. Expression of xClC-3 was carried out according to the methods described for expression of xClC-5 [66].
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mined a conductivity sequence of NO3
>Br>Cl>IH
gluconate for xClC-5 expressed in Xenopus oocytes [66].
The preference of Cl over I is in agreement with the
conductivity sequences found for ClC-5 orthologs. More-
over, it is a conserved feature of all members of the ClC
family and allows to distinguish the ClC currents from
endogenous currents that present a conductivity sequence
of I>Cl. For an unknown reason, Mo et al. [69] found
similar conductances for Cl and I for xClC-5 in oocytes.
In COS-7 cells, however, they also found a conductivity
sequence of Cl>I [82]. ClC-5 has been localised in early
endosomes in several cell types [81,83] and has been
proposed to function in the electroneutral acidification of
endosomes by the V-type proton pump (see Fig. 5C).
Interestingly, the acidification of endosomes from the prox-
imal tubule can be stimulated by anions, with Cl being
more effective than I [84].
Another characteristic that is conserved among ClC-5
orthologs is the dependence on the pH of the extracellular
medium. In our study, xClC-5 was not sensitive to increases
in the pH of the extracellular bathing medium. However,
lowering the pH was found to reversibly inhibit the xClC-5
current with a pKa value of 5.67 and a Hill coefficient of 2.2,
which is consistent with the likely dimeric structure of the
ClC channel [85–87]. Other reports on the pH sensitivity of
ClC-5 from Xenopus or other species are in agreement with
our finding [68,69,82,88], with the exception of the determi-
nation of the Hill coefficient in two reports that gave values
equal or close to 1 [69,88]. Given the intracellular localisation
of ClC-5, its inhibition by low extracellular pH is likely to
play a physiologically important role. Indeed, the luminal
space of an intracellular compartment can topologically be
considered equivalent to the extracellular space. Therefore,
the inhibition of ClC-5 conductance by an acidic luminal pH
would be consistent with a negative feedback mechanism that
allows to set the luminal pH of the intracellular compartment,
i.e. the endosomes in the proximal tubule.
Classic anion channel inhibitors, such as DIDS, NBBP,
and anthracene-9-carboxylic acid (9-AC) have been without
any effect on ClC-5 currents. We also used various other
pharmacological agents that have been described to block
anion currents (oxonol, riluzole, niflumic acid, ketocona-
zole, tamoxifen, verapamil, gossypol, diphenylamine-2-car-
bonic acid (DPC), cAMP, lanthanum) on xClC-5 currents,
but still no inhibition was observed [66]. Thus, ClC-5
appears completely insensitive to the pharmacological sub-
stances commonly used to characterise anion conductances.
However, Weng et al. [82] recently reported a significant
and reversible inhibition of the amphibian ClC-5 in the
presence of 100 AM H2O2 when expressed in COS-7 cells.
In Xenopus oocytes, however, only a high concentration (10
mM) of H2O2 or long incubation times (1 mM for 20 h)
were effective at xClC-5 inhibition. The physiological
relevance of this inhibitory effect is unknown.
The amino acid sequences of ClC-5 proteins predict
several conserved putative phosphorylation sites for protein
kinase A (PKA) and PKC. Several groups therefore attemp-
ted to inhibit the ClC-5 conductance with PKC inhibitors
(Ref. [82]; our unpublished data) or to stimulate the con-
ductance by increasing the intracellular level of cAMP (Ref.
[62,82]; our unpublished data). Both approaches were with-
out success but Weng et al. [82] reported the inhibition of
the xClC-5 conductance by 10 AM H-89, a potential
inhibitor of PKA. Whether other ClC-5 orthologs are also
inhibited by H-89 and whether this inhibition is mediated
through PKA remains to be determined. Interestingly, the
chloride conductance involved in the acidification of prox-
imal tubule endosomes has been described to be regulated
by PKA [89].
We also investigated the effect of several tyrosine kinase
inhibitors on xClC-5 expressed in Xenopus oocytes (our
unpublished results). Geldanamycin and cinnamic acid had
no effect on xClC-5 currents. However, genistein another
potent tyrosine kinase inhibitor was found to inhibit the
current significantly and reversibly (Fig. 4). Daidzein, the
inactive structural analog of genistein did not produce this
inhibitory effect on ClC-5, indicating that genistein does not
Fig. 4. xClC-5 current is inhibited by the tyrosine kinase inhibitor genistein.
(A) Current/voltage relationships of oocytes expressing xClC-5 under
control conditions, after 5 min perfusion with 100 AM genistein, and after 5
min of wash-out of the inhibitor. An inhibition of 41F 2% was achieved
after 5 min of perfusion with genistein. Only 50% of this inhibition could be
recovered after a 5 min wash-out period. Daidzein as a control was
ineffective (not shown). (B) Inhibition of xClC-5 by 10, 25 and 100 AM
genistein. Represented are the percentage of inhibition of the currents
measured at + 80 mV (our unpublished data). Methods for cRNA injection
and electrical recordings are as described in Ref. [66].
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directly interact with ClC-5. In addition, tyrphostin 51, yet
another tyrosine kinase inhibitor, was also able to reduce the
ClC-5 conductance. These inhibitory effects of genistein
and tyrphostin 51 could also be observed on the human ClC-
5. Further work is needed to investigate the regulation of
ClC-5 by tyrosine kinases.
6.2.2. Distribution
In Xenopus, RPA have shown that xClC-5 is a rather
broadly expressed gene with highest transcription levels in
oocytes, kidney, and intestine [56]. xClC-5 is also present in
liver, blood, brain, heart, and urinary bladder. We also
examined the tissue distribution in X. laevis by Western
blot using a polyclonal antibody against the 16 C-terminal
amino acids of the xClC-5 protein. High expression levels
were found in kidney and intestine, and much lower levels
in brain and heart. This distribution was confirmed with a
different antibody directed against the N-terminal region of
rClC-5 (kindly provided by T. Jentsch) (Fig. 5A). High ClC-
5 mRNA levels were also reported in kidney, intestine and
gill of the teleost fish, Oreochromis mossambicus [60]. In
contrast, in rodents and human, the ClC-5 expression levels
are elevated only in kidney [81,90], and much lower in
intestine [83]. Thus, the expression of ClC-5 seems to be
more restricted in higher vertebrates then in lower verte-
brates like Xenopus and Oreochromis.
6.2.3. Localisation and functional model
We examined the subcellular localisation of ClC-5 in A6
cells by immunofluorescence (Fig. 5B, our unpublished
data). As expected, xClC-5 protein was abundantly ex-
pressed in this cell line derived from Xenopus distal tubule.
The protein was localised in intracellular compartments
throughout the cytosol and concentrated in the perinuclear
region. In O. mossambicus, it has also been established that
ClC-5 functions as an intracellular channel [60].
In rodent kidney, ClC-5 was found in the proximal and
collecting tubule, as well as in the thick ascending limb of
Henle’s loop [81,90–92]. In rat proximal tubule, ClC-5 was
localised predominantly in cytoplasmic vesicles below the
brush border where it co-localises with the proton pump
[81,90] and with fluorescently labelled endocytosed proteins
Fig. 5. Tissue distribution and localisation of xClC-5. (A) The tissue distribution of xClC-5 was examined in Xenopus with anti-ClC-5 antibodies described in
Ref. [81]. Bands of different molecular weights could be detected in xClC-5 cRNA-injected oocytes, kidney, intestine, and brain. The highest band (130 kDa,
arrowhead) was predominant in cRNA-injected oocytes and kidney and is likely to correspond to a highly glycosylated form of xClC-5. A faint band was seen
in heart. Brain and intestine presented a predominant lower band (at about 85 kDa, arrowhead). The same pattern of bands was observed with our antibody
(antibody described in Ref. [66]). The 50 kDa band observed in oocytes corresponds probably to a nonspecific band as it can also be observed in noninjected
control oocytes (data not shown). Methods are as described in Ref. [66]. Briefly, 50 Ag of Xenopus oocytes and 150 Ag of Xenopus tissues were separated by
SDS-PAGE, electrotransfered onto nitrocellulose membrane, and incubated overnight with the anti-ClC-5 antibodies, kindly provided by T. Jentsch. (Our
unpublished data.) (B) Immunolocalisation of xClC-5 in A6 cells grown on coverslips. Cells were fixed in 2% paraformaldehyde. Primary anti-ClC-5
antibodies were described previously [66] and used at 1:50. Secondary antibodies were FITC-conjugated, and were used at 1:300. Bar: 10 Am. (Our
unpublished data.) (C) Functional model for ClC-5 (model modified from Ref. [104]). ClC-5 co-localises with proton pumps in early endosomes in proximal
tubule cells [104]. Parallel functioning of the proton pumps and ClC-5 channels allows the acidification of early endosomes involved in recycling and
degradation of apical receptors and reabsorption of low molecular weight proteins.
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[81]. Staining of the brush border was also reported [90].
The co-localisation of ClC-5 with proton pumps in endo-
somes led the authors [81] to propose that ClC-5 may
function in parallel in the acidification of endosomes, by
providing the electrical shunt required for proper function-
ing of the V-ATPase (Fig. 5C). Subsequently, this hypoth-
esis was further supported by a knock-out mouse model in
which the ClC-5 gene was disrupted [93]. In these mice,
fluid-phase and receptor-mediated endocytosis were im-
paired, as a consequence of ClC-5 disruption. ClC-5 is also
expressed in a- and h-intercalated cells of the collecting
duct that are involved in acid and base excretion, respec-
tively [81,90]. In a-intercalated cells, ClC-5 was found to
co-localise with the proton pumps in apical vesicles, and
was suggested to be a key element for endosome acid-
ification and proton secretion into the lumen [90].
By analogy with the proposed model for ClC-5 function
in endosomes, it is tempting to speculate about ClC-5
function in the frog skin epithelium. One could imagine
ClC-5 functioning in parallel to the V-ATPases in the ‘‘pit’’
of MR cells (Fig. 1). Acidosis modulates proton secretion
and the rate of vesicle exocytosis in the frog skin epithelium
[25,94]. Thus, acidosis could trigger the exocytosis of ClC-5
containing vesicles, providing a regulatory mechanism to
control V-ATPase activity (proton excretion). Immunocyto-
chemical studies to localise xClC-5 in the proton secreting
frog skin epithelia and functional studies would be neces-
sary to test this hypothetical model for ClC-5 function in the
frog skin.
6.3. xClC-K
A third member of the ClC family has been cloned from
Xenopus [55]. Comparison with other members of the ClC
gene family showed that the sequence is most closely
related to the ClC-K subbranch. It shares 60–62% similarity
with its rat and human orthologs, respectively, and has been
named xClC-K. This cDNA encodes a 77 kDa protein
presenting about 30% similarity with Xenopus ClC-3 and
ClC-5. ClC-Ka and ClC-Kb channels represent two closely
related members (approximately 90% identity) within the
ClC gene family [95–97]. Both channels are predominantly
expressed in the kidney [95–97], but are also present in the
inner ear [71,98]. Recently, barttin, a small protein with two
transmembrane domains, has been identified as a h subunit
for ClC-K channels, which is necessary for channel activity
[71]. There is strong evidence that the ClC-K/barttin hetero-
mers play an important role in transepithelial transport in the
kidney and the stria vascularis. In human, mutations in ClC-
Ka lead to nephrogenic diabetis insipidus [99], suggesting
that ClC-Ka may be involved in the chloride transport in the
thin ascending loop of Henle. ClC-Kb was found to mediate
the basolateral chloride efflux in the thick ascending limb of
Henle’s loop and mutations of ClC-Kb are responsible for
Bartter’s syndrome [100]. The role of ClC-K in Xenopus
kidney remains to be determined.
6.4. Other ClC family members
Five additional ClC genes (ClC-1, ClC-2, ClC-4, ClC-6,
and ClC-7) have been cloned in mammals (for a review, see
Ref. [1]), but no amphibian orthologs have been reported so
far. ClC-1 is expressed in skeletal muscle where it is
involved in the stabilisation of membrane potential. ClC-2
is ubiquitously expressed, slowly activated upon hyperpola-
rization, cell swelling, and extracellular acidification. Its
physiological function(s) remains to be established. In the
apical membrane of rat choroid plexus, an inward-rectifying
anion conductance with a significant permeability for
HCO3
, closely resembling the ClC-2 conductance has been
identified [101]. Interestingly, a similar anion conductance
permeable for HCO3
 was also described in amphibian
choroid plexus [102]. ClC-4, ClC-6, and ClC-7 have broad
tissue distributions and are likely to be intracellular. The
physiological function(s) of ClC-4 and ClC-6 remain to be
elucidated. Disruption of ClC-7 leads to osteopetrosis in
mice and human [103].
In addition to ClC-K, ClC-3, and ClC-5, amphibians
might possess other ClC family members. Future studies
should address this question and elucidate whether ClC
channels serve the same functions in amphibian as in
mammals.
7. Concluding remarks
Amphibians provide model systems to study transepithe-
lial transports involved in ionic homeostasis and acid–base
balance, and cell volume regulation. The fundamental lines
defining active sodium reabsorption were established in
1958 by Koefoed-Johnsen and Ussing [14], when the frog
skin epithelium was mounted between two chambers and
the two-membrane model for Na+ uptake was first de-
scribed. Since then, studying the frog skin epithelium
provided us with numerous insights into the various trans-
port mechanisms underlying different cell physiological
processes. More then two decades later, modern molecular
biology tools became available and allowed the molecular
identification of pumps, transporters, and channels. It took
yet another decade before the first chloride channel was
cloned from an amphibian organism: Xenopus CFTR. Sub-
sequently, three members of the ClC family of chloride
channels have also been identified from Xenopus: ClC-K,
ClC-3, and ClC-5. However, the functional expression of a
cloned channel protein does not necessarily provide an
immediate understanding of its physiological function.
The amphibian CFTR was localised in MR cells of the
skin epithelium of the toad, and has been proposed to
function in the transepithelial chloride transport under con-
trol of the h-adrenergic receptor [14].
Xenopus ClC-K is not yet characterised at the electro-
physiological level. The recent identification of barttin as a
h subunit for ClC-K shed light on the functioning of ClC-K
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channels [71]. Future studies aiming at the functional
characterisation of ClC-K in Xenopus will have to determine
whether the function of the amphibian ClC-K also requires
the association with an amphibian homologue of barttin.
ClC-3 and ClC-5 appear as intracellular chloride chan-
nels in Xenopus as in mammals. Functional models are
proposed involving both proteins in acidification of intra-
cellular compartments, by providing the electric shunt for
electroneutral functioning of V-type ATPases. Future studies
ought to examine the possibility that in some cell types (i.e.
MR cells in the skin epithelium and intercalated cells in the
kidney), these chloride channels might localise at the plasma
membrane to function in proton excretion in parallel with
plasma membrane proton pumps.
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